Special Issue "Roles, Responsibilities and Duties of the Pharmacist in COVID-19 Management"
A special issue of Pharmacy (ISSN 2226-4787).
Deadline for manuscript submissions: 31 August 2021.
Interests: legal and forensic medicine; bioethics; public health; college of physicians; risk management
Interests: computational and mathematical epidemiology; biomathematics; public health
Special Issues and Collections in MDPI journals
Special Issue in Nutrients: The Impact of Fasting on Human Health: Which Is the Current Evidence?
Special Issue in International Journal of Environmental Research and Public Health: Big Data and Mathematical Modeling in Biomedicine
Special Issue in Pharmacy: Pharmacists as Immunizers: The Role of Pharmacies in Promoting Immunization Campaigns and Counteracting Vaccine Hesitancy
Special Issue in International Journal of Environmental Research and Public Health: Climate Change: An Often-Missed Cause of Occupational Injuries?
Since late December 2019, a novel, emerging coronavirus has been identified as the infectious agent responsible for a generally mild but sometimes severe and even life- threatening disease, termed as “coronavirus disease 2019” (COVID-19). The pathogen has been named as “Severe Acute Respiratory Coronavirus type 2” (SARS-CoV-2). COVID-19 quickly spread from the first epicenter, the city of Wuhan, province of Hubei, mainland China, into neighboring countries, and became a global pandemic. COVID-19 has challenged health systems, straining and overwhelming healthcare facilities and settings, including hospital and community pharmacies. On the other hand, the COVID-19 outbreak has unearthed new opportunities for pharmacists: community and hospital pharmacists have, indeed, played a key role during the COVID-19 pandemic, acquiring more professional standing, being authentic frontline health workers.
Prof. Alessandro Bonsignore
Prof. Nicola Luigi Bragazzi
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmacy is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Community pharmacists
- Hospital pharmacists
- Increased scope of practice
- Roles, responsibilities, and duties
- Frontline workers
The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.
Title: In the Eye of the Storm: Role of the Pharmacist in Medication Safety During the COVID-19 Pandemic
Authors: Abir O. Kanaan; Karyn M. Sullivan; Sheila M. Seed; Nathan A. Cookson; Linda M. Spooner; George M. Abraham
Affiliation: School of Pharmacy Worcester-Manchester/ MCPHS University
Abstract: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), the virus responsible for the coronavirus disease (COVID-19) pandemic, has challenged practitioners with complex clinical scenarios as well as conflicting and scarce data to support treatment strategies. The pandemic has also placed strains on institutions due to drug shortages, alterations in medication use processes, economic losses, and staff exposure to the virus. This article provides pharmacist-led suggestions and strategies to various case questions describing some of the challenges faced by practitioners and institutions during the COVID-19 pandemic. The strategies suggested can be applied at other institutions.